Immunoassay Market Research, Strategies, Trends and Forecasts Report 2025 with Executive Guides and Impact of Artificial Intelligence - ResearchAndMarkets.com

DUBLIN--( BUSINESS WIRE)--The "Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides, Impact of Artificial Intelligence" has been added to ResearchAndMarkets.com's offering.

The diagnostic industry's pace is quickening as new demands emerge post-pandemic, driving a resurgence in rapid and accessible diagnostics. This evolution positions immunoassay technology at the forefront, as it capitalizes on advancements in genetic knowledge to tap into fresh markets. The rise of multiplexing has become an essential component, elevating the stakes for industry participants. The landscape is evolving with rapid diagnostics, point-of-care solutions, biomarkers, and consumer markets offering expansive growth opportunities, alongside traditional immunoassays that continue to bolster their stronghold in clinical diagnostics.

This shift sees over 60 companies, both established giants and agile newcomers, navigating this dynamic field. An analytical report reveals the intricacies of this market, shedding light on both potential pitfalls and lucrative opportunities. Equipped with detailed company profiles, stakeholders can gain a comprehensive understanding, paving the way for informed investment decisions and accurate valuations. This extensive report empowers industry participants to leverage the latest data, ensuring strategic decisions are made with clarity and precision.

With the convergence of sophisticated genetic insights and the pressing need for swift diagnostic solutions, the immunoassay sector is poised for substantial growth. As multiplex becomes standard practice, the industry's adaptability is tested, urging companies to innovate continuously to maintain competitiveness. The expansion into point-of-care diagnostics and consumer markets not only presents fertile ground for development but also challenges firms to meet heightened expectations for accuracy, speed, and accessibility.

Market players are diligently advancing the capabilities of rapid diagnostics and leveraging advancements in biomarkers to fulfill the increasing demand for personalized healthcare solutions. This expansive report provides a deep dive into the current market trends, future projections, and strategic insights required to harness the potential within this thriving domain.

In this rapidly evolving landscape, professionals and investors armed with the latest insights can navigate the complexities of the immunoassay market confidently. The report stands as an essential tool, delivering comprehensive data analysis to facilitate strategic decision-making processes. By staying at the forefront of technological advancements and market shifts, industry leaders can position themselves for sustained success amid a backdrop of ever-growing diagnostic needs.

Key Topics Covered:

1 Market Guides

1.1 Immunoassay Market - Strategic Situation Analysis

1.2 Guide for Executives, Marketing, Sales and Business Development Staff

1.3 Guide for Management Consultants and Investment Advisors

2 Introduction and Market Definition

2.1 Immunoassay Markets Definition In This Report

2.2 Market Definition

2.3 Methodology

2.4 Perspective: Healthcare and the IVD Industry

3 Industry Overview

3.1 Players in a Dynamic Market

3.1.1 Academic Research Lab

3.1.2 Diagnostic Test Developer

3.1.3 Instrumentation Supplier

3.1.4 Chemical/Reagent Supplier

3.1.5 Pathology Supplier

3.1.6 Independent Clinical Laboratory

3.1.7 Public National/regional Laboratory

3.1.8 Hospital Laboratory

3.1.9 Physicians Office Lab (POLS)

3.1.10 Audit Body

3.1.11 Certification Body

3.2 The Clinical Laboratory Market Segments

3.2.1 Traditional Market Segmentation

3.2.2 Laboratory Focus and Segmentation

3.2.3 Hospital Testing Share

3.2.4 Economies of Scale

3.2.5 Hospital vs. Central Lab

3.2.6 Physician Office Lab's

3.2.7 Physician's and POCT.

3.3 Immunoassay - Markets and Discussion

3.3.1 Instruments - Genetics changes the picture

3.3.2 Reagents and Kits - Genetics changes the picture

3.3.4 OTC and DTC - Huge Market Potential

3.3.5 Economies of Scale. Going Away?

3.3.6 Lower Barriers to Entry for Instruments/Analyzers

3.3.7 Miniturization and Technology Drive Acquisition

4 Market Trends

4.1 Factors Driving Growth

4.1.1 Diagnostic Factors

4.1.2 Changing Technologies Spur Early Instrument Retirement

4.1.3 Consumer Channels Open Wider

4.1.4 Immunity Technology Comes of Age

4.2 Factors Limiting Growth

4.2.1 Increased Competition Lowers Price

4.2.2 Threat from PCR Based Instruments

4.2.3 Lower Barriers to Entry

4.2.4 Wellness has a downside

4.3 Immunoassay Instrumentation

4.3.1 Instrumentation Tenacity

4.3.2 Declining Cost of Instruments Changes Industry Structure

4.3.3 LISTING of INSTRUMENT SPECIFICATIONS

4.3.4 Immunoassay - CRISPR Diagnostics

5 Immunoassay Recent Developments

5.1 Recent Developments - Importance and How to Use This Section

5.1.1 Importance of These Developments

5.1.2 How to Use This Section

5.2 EDP Biotech, New Day Diagnostics to Merge

5.3 Sorrento Therapeutics Nabs Contract for Dx Platform

5.4 Beckman Coulter Diagnostics DxI 9000 Access Immunoassay Analyzer

5.5 Qorvo Eyes Multiplex Immunoassay

5.6 BioMerieux Launches New Products

5.7 Senzo to Commercialize Infectious Disease Lateral Flow Tests

5.8 Nanomix Plans Instrument, Test Launches

5.9 Startup GLX Analytix Prepares for Commercialization

5.10 Nonagen Gets CE Mark for Bladder Cancer Immunoassay

5.11 Qualigen Acquires Majority Stake in NanoSynex

5.12 Saladax Biomedical Using Immunoassay Dx

5.13 Prolight Diagnostics to Acquire Psyros Diagnostics

5.14 Quidel to Acquire Ortho Clinical Diagnostics

5.15 FDA Grants EUA to Xtrava Health

5.16 Alamar Biosciences Develops Immuno-Sandwich Platform

5.17 FDA grants breakthrough device to multiplex immunoassay

5.18 Quidel, Beckman Settle Cardiac Immunoassay Dispute

5.19 BGI Americas, Advaite Form SARS-CoV-2 Testing Partnership

5.20 BioMerieux Gets CE Mark for Three Dengue Immunoassays

5.21 COVID-19 Portfolio to Accelerate At-Home Infectious Disease Testing

5.22 Roche Diagnostics Expanding Testing Portfolio in 2021

5.23 PerkinElmer Long-Term Outlook

5.24 Quidel Updates Outlook for C19 Testing

5.25 Dx Companies Look at Multiplex Tests for SARS-CoV-2, Influenza

5.26 Becton Dickinson and NAT Diagnostics Acquisition

6 Profiles of Key Companies

6.1 Abbott Laboratories

6.2 Abcam

6.3 Abionic

6.4 Accel Diagnostics

6.5 Applied BioCode

6.6 Arlington Scientific

6.7 Arrayit Corporation

6.8 Atomo Diagnostics

6.9 Aureum Diagnostics

6.10 Aurora Biomed

6.11 Autobio Diagnostics

6.12 AVIVA Systems Biology

6.13 Awareness Technology

6.14 Axis-Shield Diagnostics Ltd.

6.15 Beckman Coulter Diagnostics

6.16 Becton, Dickinson and Company

6.17 Biocartis

6.18 Biomatik

6.19 bioMerieux Diagnostics

6.20 Bioneer Corporation

6.21 Bio-Rad Laboratories, Inc.

6.22 BioTek Instruments

6.23 Boditech Med, Inc

6.24 Boster Biological Technology

6.25 Diamedix (Erba Diagnostics)

6.26 Diasorin S.p.A.

6.27 Dynex Technologies

6.28 Enzo Biochem

6.29 Eurofins Scientific

6.30 FUJIFILM Wako Diagnostics

6.31 Fujirebio

6.32 Gold Standard Diagnostics

6.33 Grifols

6.34 Hycor Biomedical

6.35 Immunodiagnostic Systems (IDS)

6.36 Immunodiagnostik AG

6.37 Inova Diagnostics

6.38 JR Biomedical

6.39 Luminex Corp

6.40 Maxim Biomedical

6.41 Mbio Diagnostics

6.42 Meso Scale Discovery

6.43 Millipore Sigma

6.44 Mindray

6.45 Molecular Devices

6.46 MP Biomedical

6.47 Operon

6.48 Ortho Clinical Diagnostics

6.49 Perkin Elmer

6.50 Qiagen

6.51 Quidel

6.52 R&D Systems

6.53 Randox Toxicology

6.54 Roche Molecular Diagnostics

6.55 SD Biosensor

6.56 Siemens Healthineers

6.57 Sysmex

6.58 Tecan

6.59 Thermo Fisher Scientific Inc.

6.60 TOSOH Bioscience

6.61 Veredus Laboratories

6.62 Vircell

6.63 YD Diagnostics

6.64 Zhejiang Orient Gene Biotech

7 The Global Market

7.1 Global Market by Country

7.2 Global Market by Application

7.3 Global Market by Technology

7.4 Global Market by Product

7.5 Global Market by User

8 Global Market by Application

8.1 Endocrinology Applications

8.2 Immune Applications

8.3 Oncology Applications

8.4 Infectious Disease Applications

8.5 Cardiology Applications

8.6 Other Applications

9 Immunoassay by Technology

9.1 Enzyme

9.2 Flourescence

9.3 Chemiluminescence

9.4 Nucleic Acid

9.5 Rapid/POC

9.6 Other Technology

10 Immunoassay by Product

10.1 Instrument

10.2 Reagents

10.3 Services

11 Immunoassay by User

11.1 Hospital

11.2 Outpatient Lab

11.3 POC/Other

12 Vision of the Future of Immunoassay

13 Appendices

13.1 United States Medicare System: Laboratory Fees Schedule

13.2 The Most Used IVD Assays

13.3 The Highest Grossing Assays

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/f9yc3f

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.